Source: Frontiers in Oncology. Unidade: FMRP
Subjects: APOPTOSE, ADENOCARCINOMA, PRÓSTATA, NEOPLASIAS DOS GENITAIS MASCULINOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE GRANDIS, Rone A et al. A novel Ruthenium(II) complex with lapachol induces G2/M phase arrest through Aurora-B kinase down-regulation and ROS-mediated apoptosis in human prostate adenocarcinoma cells. Frontiers in Oncology, v. 11, 2021Tradução . . Disponível em: https://doi.org/10.3389/fonc.2021.682968. Acesso em: 28 abr. 2026.APA
De Grandis, R. A., Oliveira, K. M., Guedes, A. P. M., Santos, P. W. da S. dos, Aissa, A. F., Batista, A. A., & Pavan, F. R. (2021). A novel Ruthenium(II) complex with lapachol induces G2/M phase arrest through Aurora-B kinase down-regulation and ROS-mediated apoptosis in human prostate adenocarcinoma cells. Frontiers in Oncology, 11. doi:10.3389/fonc.2021.682968NLM
De Grandis RA, Oliveira KM, Guedes APM, Santos PW da S dos, Aissa AF, Batista AA, Pavan FR. A novel Ruthenium(II) complex with lapachol induces G2/M phase arrest through Aurora-B kinase down-regulation and ROS-mediated apoptosis in human prostate adenocarcinoma cells [Internet]. Frontiers in Oncology. 2021 ; 11[citado 2026 abr. 28 ] Available from: https://doi.org/10.3389/fonc.2021.682968Vancouver
De Grandis RA, Oliveira KM, Guedes APM, Santos PW da S dos, Aissa AF, Batista AA, Pavan FR. A novel Ruthenium(II) complex with lapachol induces G2/M phase arrest through Aurora-B kinase down-regulation and ROS-mediated apoptosis in human prostate adenocarcinoma cells [Internet]. Frontiers in Oncology. 2021 ; 11[citado 2026 abr. 28 ] Available from: https://doi.org/10.3389/fonc.2021.682968
